A class action lawsuit accuses Procter & Gamble (P&G) of omitting PFAS (forever chemicals) from Oral-B Glide floss, potentially harming users’ health. P&G denies the claims and asserts product safety. The ongoing case raises concerns about PFAS in dental floss and wider health implications.
| Complete Date | Case Name | Citation | Court | Short Summary |
|---|---|---|---|---|
| January 11, 2022 | Dalewitz v. The Procter & Gamble Co. | Case No. 7:22-cv-07323 (NSR) | U.S. District Court for the Southern District of New York | The lawsuit claims P&G failed to disclose PFAS in Oral-B Glide, potentially causing health issues like cancer and reproductive problems. It accuses P&G of false advertising and deceptive practices. |
| September 22, 2023 | Judge Nelson Roman dismisses the case, finding insufficient evidence to prove PFAS presence in the floss or link it to harm. Plaintiffs have until October 23, 2023, to file an amended complaint. | |||
| October 26, 2023 | P&G Statement | Press Release | N/A | P&G reiterates product safety, transparency commitment, and continued information provision. |
| Present Day (February 1, 2024) | Plaintiffs have not filed an amended complaint, leaving the case dismissed as of now. Concerns about PFAS in dental floss persist, prompting discussions and potential regulatory actions. |
- The original lawsuit focused on alleged PFAS presence and health risks, claims the judge deemed unsubstantiated.
- The dismissal allows plaintiffs to revise their complaint and address the judge’s concerns.
- Whether a revised complaint will be filed and the case will continue is unclear.
- The case highlights concerns about PFAS in consumer products and potential health implications, but no definitive conclusions were drawn.
